Abstract | AIMS: METHODS AND RESULTS: Consecutive cases of HCC (n = 430) were classified into K19+ and K19- using immunohistochemistry. ICCA cases were also separated into small-(S-iCCA; n = 36) and large-duct types (n = 22) based on recently proposed criteria, with the former being used in the present study. Mutational hot-spots in TERT, CTNNB1, KRAS and IDH1 were sequenced. Twenty-six cases (6%) of HCC expressed K19. K19+ HCC was more strongly associated with chronic hepatitis B than K19- HCC and S-iCCA (46% versus 17% and 6%; both P < 0.001). Lymph node metastasis was observed in K19+ HCC (8%) and S-iCCA (22%), but was exceptional in K19- HCC (1%). K19+ HCC had TERT promoter mutations less frequently than K19- HCC (31% versus 59%; P = 0.022), and lacked alterations in KRAS and IDH1. CTNNB1 mutations were similarly observed in K19+ and K19- HCC (23% and 19%, respectively), but rare in S-iCCA (3%). The postoperative survival curve of K19+ HCC was almost identical to that of S-iCCA in the first 5 years (approximately 50% at 5 years), and significantly worse than that of K19- HCC (P = 0.040). Extrahepatic recurrence was more common in K19+ HCC (50%) and S-iCCA (35%) than in K19- HCC (15%) (P = 0.001). CONCLUSIONS: Although K19+ HCC and S-iCCA showed similar biological behaviours, they did not share any driver gene mutations, suggesting the possible involvement of epigenetic alterations in the iCCA-like features of K19+ HCC.
|
Authors | Masayuki Akita, Tetsuo Ajiki, Takumi Fukumoto, Tomoo Itoh, Yoh Zen |
Journal | Histopathology
(Histopathology)
Vol. 75
Issue 3
Pg. 385-393
(Sep 2019)
ISSN: 1365-2559 [Electronic] England |
PMID | 31017316
(Publication Type: Journal Article)
|
Copyright | © 2019 John Wiley & Sons Ltd. |
Chemical References |
- KRT19 protein, human
- Keratin-19
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Bile Duct Neoplasms
(genetics, metabolism, pathology)
- Carcinoma, Hepatocellular
(genetics, metabolism, pathology)
- Cholangiocarcinoma
(genetics, metabolism, pathology)
- Female
- Humans
- Keratin-19
(biosynthesis)
- Liver Neoplasms
(genetics, metabolism, pathology)
- Male
- Middle Aged
- Survival Analysis
|